| Unique ID issued by UMIN | UMIN000009620 |
|---|---|
| Receipt number | R000011289 |
| Scientific Title | Assessment of efficy and safety of everolimus in Japanese patients with mRCC |
| Date of disclosure of the study information | 2013/01/07 |
| Last modified on | 2012/12/25 15:26:08 |
Assessment of efficy and safety of everolimus in Japanese patients with mRCC
Assessment of efficy and safety of everolimus
Assessment of efficy and safety of everolimus in Japanese patients with mRCC
Assessment of efficy and safety of everolimus
| Japan |
renal cell carcinoma
| Urology |
Malignancy
NO
To assess the efficacy and safety of everolimus treatment for mRCC patients retrospectively
Safety,Efficacy
Confirmatory
Not applicable
PFS, AEs
Observational
| 20 | years-old | <= |
| Not applicable |
Male and Female
Suitable for everolimus treatment
Unsuitable for everolimus treatment
200
| 1st name | |
| Middle name | |
| Last name | Mototsugu Oya M.D. |
Keio university, school of medicine
Department of Urology
35 Shinanomachi, Shinjuku-ku
03-3353-1211
| 1st name | |
| Middle name | |
| Last name | Ryuichi Mizuno M.D. |
Keio university, school of medicine
Department of Urology
mizunor@z7.keio.jp
Tokyo Afinitor Clinical Trial Group
Ministry of Education, Culture, Sports, Science and Technology
NO
| 2013 | Year | 01 | Month | 07 | Day |
Unpublished
Terminated
| 2011 | Year | 11 | Month | 07 | Day |
| 2013 | Year | 01 | Month | 07 | Day |
Results for blood tests and radiological studies would be reviewed.
| 2012 | Year | 12 | Month | 25 | Day |
| 2012 | Year | 12 | Month | 25 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000011289